Beta Drugs Ltd. - Research Center
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
92.42 |
77.97 |
65.32 |
59.53 |
34.82 |
Operating profit |
19.16 |
15.75 |
12.63 |
12.56 |
6.67 |
Interest |
0.57 |
0.30 |
0.20 |
0.21 |
0.39 |
Gross profit |
19.25 |
15.93 |
12.77 |
12.86 |
6.54 |
EPS (Rs) |
12.60 |
10.09 |
7.18 |
7.64 |
3.18 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.66 |
0.48 |
0.35 |
0.51 |
0.27 |
Stock adjustment |
-5.82 |
-0.56 |
1.07 |
-0.21 |
-0.04 |
Raw material |
56.01 |
42.05 |
36.14 |
33.72 |
19.16 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
6.73 |
6.56 |
5.12 |
3.60 |
2.60 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
16.33 |
14.16 |
10.35 |
9.86 |
6.42 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
3.04 |
2.97 |
2.98 |
2.49 |
2.50 |
Taxation |
4.10 |
3.26 |
2.89 |
3.03 |
0.98 |
Net profit / loss |
12.11 |
9.70 |
6.91 |
7.34 |
3.06 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
9.61 |
9.61 |
9.61 |
9.61 |
9.61 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
20.74 |
20.20 |
19.33 |
21.09 |
19.15 |
GPM (%) |
20.68 |
20.31 |
19.45 |
21.41 |
18.65 |
NPM (%) |
13.01 |
12.37 |
10.52 |
12.23 |
8.73 |